Page 47 - Genomic Medicine in Emerging Economies
P. 47

36   CHAPTER 3:  Genomics and Public Health: China’s Perspective




                                The study of genomics has led to insights on gene regulation and the com-
                                plex interplay of factors at play in both Chinese medicine and in personal-
                                ized medicine (Yun et al., 2012a). Clinicians and life scientists, therefore, are
                                currently at a critical junction to accelerate both TCM and its evidence base
                                with the availability of genomics, as well as postgenomics technologies such
                                as functional genomics, proteomics, metabolomics, glycomics, and lipido-
                                mics at molecular and cellular levels. This chapter provides an outlook on the
                                enormous promise anticipated from the integration of TCM with genomics/
                                genetics as a new driver for novel molecular-targeted personalized medicine,
                                and the future directions and challenges in this hitherto neglected dimension
                                of  postgenomic-personalized  medicine.  Recently,  this has  mainly  involved
                                the systematic use of patients’ genotypes and clinical phenotypes to optimize
                                the individual’s preventive and therapeutic care (Wang and Chen, 2013; Yun
                                et al., 2012b).


                                Application of Genomics Technologies in the Authentication of
                                Traditional Chinese Medicine
                                The elements of TCM diagnoses are influenced by three principal factors:
                                heredity (genetic composition), ontogeny (stage of development), and envi-
                                ronment (climate, associated flora, soil, and method of cultivation). Genetic
                                analyses of Chinese herbs can provide leads for the botanical identity of TCM
                                constituents as the DNA profiling of a herbal species does not vary with their
                                physical form, physiology, and external conditions. Natural products are gain-
                                ing increased applications in drug discovery and development. DNA mutation
                                and polymorphism analysis lead to the applications of DNA microarrays in
                                pharmacodynamics, pharmacogenomics, toxicogenomics, and quality control
                                of herbal drugs and extracts. Genomic analyses of Chinese herbs provide the
                                botanical identity of TCM constituents (Hon et al., 2003). One of the most
                                well-studied herbs is ginseng, which has long been used to maintain physi-
                                cal vitality in China and the Far East. Ginsenosides, a main element of gin-
                                seng, can inhibit early antigen activation of Epstein-Barr virus and also shows
                                anticarcinogenic effects in a two-stage mouse skin model with 9,10-dimethyl-
                                1,2-benzanthracene and in lung carcinogenesis induced by 4-nitroquinolin-
                                1-oxide (Konoshima et al., 1996; Zhang et al., 2013). The DNA probe method
                                for the identification of host-specific DNA fragments has been employed in
                                DNA fingerprinting analysis of ginseng and generated a distinctive banding
                                pattern,  with  a homologous  index  of  0.55  between  Chinese and  American
                                ginseng (Ho and Leung, 2002). In another investigation, the random ampli-
                                fied polymorphic DNA (RAPD) technique has been used to identify the Panax
                                species and their adulterant, and distinct RAPD fingerprints of American and
                                Chinese ginseng have been obtained, irrespective of sources and ages (Shaw
                                and But, 1995). Restriction fragment length polymorphic DNA is also applied
                                on ginseng authentication based on the ribosomal ITS1-5.8S-ITS2 region and
   42   43   44   45   46   47   48   49   50   51   52